Prognostic Correlation of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in 1307 Primary Breast Cancers
Barbro Linderholm(Karolinska University Hospital), Roger Henriksson(Umeå University), Jonas Bergh(Karolinska Institutet), Kjell Grankvist(Umeå University), Martin Erlanson(Karolinska Institutet), Birgitta Lindh(Uppsala University Hospital), K. Edin(Sundsvall Municipality), Björn Tavelin, L. Beckman(Max Planck Institute of Psychiatry)
Cited by 74
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k